Cargando…
COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
Autores principales: | Sookaromdee, Pathum, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425075/ https://www.ncbi.nlm.nih.gov/pubmed/34509271 http://dx.doi.org/10.1016/j.aohep.2021.100525 |
Ejemplares similares
-
Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
Severe immune thrombocytopenia following COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
AIDS and monkeypox: Cooccurrence and clinical concern on immunodeficiency
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Dead Body of the Patient with COVID-19 and Concern on Disease Spreading
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
COVID-19 Vaccine-Induced Immune Response in Oral Fluids and Serum: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)